Loading…
Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration
[Display omitted] Intraperitoneal (IP) drug delivery of chemotherapeutic agents, administered through hyperthermal intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosolized chemotherapy (PIPAC), is effective for the treatment of peritoneal malignancies. However, these therapeu...
Saved in:
Published in: | International journal of pharmaceutics 2022-06, Vol.622, p.121828-121828, Article 121828 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783 |
---|---|
cites | cdi_FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783 |
container_end_page | 121828 |
container_issue | |
container_start_page | 121828 |
container_title | International journal of pharmaceutics |
container_volume | 622 |
creator | Teja Surikutchi, Bhanu Obenza-Otero, Rebeca Russo, Emanuele Zelzer, Mischa Golán Cancela, Irene Costoya, José A. Crecente Campo, José José Alonso, Maria Marlow, Maria |
description | [Display omitted]
Intraperitoneal (IP) drug delivery of chemotherapeutic agents, administered through hyperthermal intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosolized chemotherapy (PIPAC), is effective for the treatment of peritoneal malignancies. However, these therapeutic interventions are cumbersome in terms of surgical practice and are often associated with the formation of peritoneal adhesions, due to the catheters inserted into the peritoneal cavity during these procedures. Hence, there is a need for the development of drug delivery systems that can be administered into the peritoneal cavity. In this study, we have developed a nanocapsule (NCs)-loaded hydrogel for drug delivery in the peritoneal cavity. The hydrogel has been developed using poly(ethylene glycol) (PEG) and thiol-maleimide chemistry. NCs-loaded hydrogels were characterized by rheology and their resistance to dilution and drug release were determined in vitro. Using IVIS® to measure individual organ and recovered gel fluorescence intensity, an in vivo imaging study was performed and demonstrated that NCs incorporated in the PEG gel were retained in the IP cavity for 24 h after IP administration. NCs-loaded PEG gels could find potential applications as biodegradable, drug delivery systems that could be implanted in the IP cavity, for example at a the tumour resection site to prevent recurrence of microscopic tumours. |
doi_str_mv | 10.1016/j.ijpharm.2022.121828 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2667786710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517322003830</els_id><sourcerecordid>2667786710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783</originalsourceid><addsrcrecordid>eNqFkMtu2zAURImgReI4-YQUWnYjhw_x4VUQuG1awEA27ZqgyCuHBkWqpGTAf185drvt6gKDmTuYg9ADwSuCiXjcr_x-eDO5X1FM6YpQoqi6QguiJKtZI8UHtMBMqpoTyW7QbSl7jLGghF2jG8b5muOGLJD5AgcIaeghjlXqKlNFE5M1Q5kC1CEZB656O7qcdhCqLuXK5WlXOQj-APn4rvg4ZjNA9mOKYEJlXO-jL7M4-hTv0MfOhAL3l7tEv759_bn5Xm9fX35snre1bQgda9u11jjTdS1uFHFMtYK5FlSLsRKNawjjqhFcAsOklZTbzlBLueJ2jem8ky3R5_PfIaffE5RR975YCMFESFPRVAgplZAEz1Z-ttqcSsnQ6SH73uSjJlif6Oq9vtDVJ7r6THfOfbpUTG0P7l_qL87Z8HQ2wDz04CHrYj1EC85nsKN2yf-n4g9xdI-n</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2667786710</pqid></control><display><type>article</type><title>Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration</title><source>Elsevier</source><creator>Teja Surikutchi, Bhanu ; Obenza-Otero, Rebeca ; Russo, Emanuele ; Zelzer, Mischa ; Golán Cancela, Irene ; Costoya, José A. ; Crecente Campo, José ; José Alonso, Maria ; Marlow, Maria</creator><creatorcontrib>Teja Surikutchi, Bhanu ; Obenza-Otero, Rebeca ; Russo, Emanuele ; Zelzer, Mischa ; Golán Cancela, Irene ; Costoya, José A. ; Crecente Campo, José ; José Alonso, Maria ; Marlow, Maria</creatorcontrib><description>[Display omitted]
Intraperitoneal (IP) drug delivery of chemotherapeutic agents, administered through hyperthermal intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosolized chemotherapy (PIPAC), is effective for the treatment of peritoneal malignancies. However, these therapeutic interventions are cumbersome in terms of surgical practice and are often associated with the formation of peritoneal adhesions, due to the catheters inserted into the peritoneal cavity during these procedures. Hence, there is a need for the development of drug delivery systems that can be administered into the peritoneal cavity. In this study, we have developed a nanocapsule (NCs)-loaded hydrogel for drug delivery in the peritoneal cavity. The hydrogel has been developed using poly(ethylene glycol) (PEG) and thiol-maleimide chemistry. NCs-loaded hydrogels were characterized by rheology and their resistance to dilution and drug release were determined in vitro. Using IVIS® to measure individual organ and recovered gel fluorescence intensity, an in vivo imaging study was performed and demonstrated that NCs incorporated in the PEG gel were retained in the IP cavity for 24 h after IP administration. NCs-loaded PEG gels could find potential applications as biodegradable, drug delivery systems that could be implanted in the IP cavity, for example at a the tumour resection site to prevent recurrence of microscopic tumours.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2022.121828</identifier><identifier>PMID: 35595041</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Intraperitoneal delivery ; Localised drug ; Localised drug delivery ; Nanocapsule ; Ovarian cancer ; PEG hydrogel ; Peritoneal metastases</subject><ispartof>International journal of pharmaceutics, 2022-06, Vol.622, p.121828-121828, Article 121828</ispartof><rights>2022</rights><rights>Copyright © 2022. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783</citedby><cites>FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35595041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teja Surikutchi, Bhanu</creatorcontrib><creatorcontrib>Obenza-Otero, Rebeca</creatorcontrib><creatorcontrib>Russo, Emanuele</creatorcontrib><creatorcontrib>Zelzer, Mischa</creatorcontrib><creatorcontrib>Golán Cancela, Irene</creatorcontrib><creatorcontrib>Costoya, José A.</creatorcontrib><creatorcontrib>Crecente Campo, José</creatorcontrib><creatorcontrib>José Alonso, Maria</creatorcontrib><creatorcontrib>Marlow, Maria</creatorcontrib><title>Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>[Display omitted]
Intraperitoneal (IP) drug delivery of chemotherapeutic agents, administered through hyperthermal intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosolized chemotherapy (PIPAC), is effective for the treatment of peritoneal malignancies. However, these therapeutic interventions are cumbersome in terms of surgical practice and are often associated with the formation of peritoneal adhesions, due to the catheters inserted into the peritoneal cavity during these procedures. Hence, there is a need for the development of drug delivery systems that can be administered into the peritoneal cavity. In this study, we have developed a nanocapsule (NCs)-loaded hydrogel for drug delivery in the peritoneal cavity. The hydrogel has been developed using poly(ethylene glycol) (PEG) and thiol-maleimide chemistry. NCs-loaded hydrogels were characterized by rheology and their resistance to dilution and drug release were determined in vitro. Using IVIS® to measure individual organ and recovered gel fluorescence intensity, an in vivo imaging study was performed and demonstrated that NCs incorporated in the PEG gel were retained in the IP cavity for 24 h after IP administration. NCs-loaded PEG gels could find potential applications as biodegradable, drug delivery systems that could be implanted in the IP cavity, for example at a the tumour resection site to prevent recurrence of microscopic tumours.</description><subject>Intraperitoneal delivery</subject><subject>Localised drug</subject><subject>Localised drug delivery</subject><subject>Nanocapsule</subject><subject>Ovarian cancer</subject><subject>PEG hydrogel</subject><subject>Peritoneal metastases</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkMtu2zAURImgReI4-YQUWnYjhw_x4VUQuG1awEA27ZqgyCuHBkWqpGTAf185drvt6gKDmTuYg9ADwSuCiXjcr_x-eDO5X1FM6YpQoqi6QguiJKtZI8UHtMBMqpoTyW7QbSl7jLGghF2jG8b5muOGLJD5AgcIaeghjlXqKlNFE5M1Q5kC1CEZB656O7qcdhCqLuXK5WlXOQj-APn4rvg4ZjNA9mOKYEJlXO-jL7M4-hTv0MfOhAL3l7tEv759_bn5Xm9fX35snre1bQgda9u11jjTdS1uFHFMtYK5FlSLsRKNawjjqhFcAsOklZTbzlBLueJ2jem8ky3R5_PfIaffE5RR975YCMFESFPRVAgplZAEz1Z-ttqcSsnQ6SH73uSjJlif6Oq9vtDVJ7r6THfOfbpUTG0P7l_qL87Z8HQ2wDz04CHrYj1EC85nsKN2yf-n4g9xdI-n</recordid><startdate>20220625</startdate><enddate>20220625</enddate><creator>Teja Surikutchi, Bhanu</creator><creator>Obenza-Otero, Rebeca</creator><creator>Russo, Emanuele</creator><creator>Zelzer, Mischa</creator><creator>Golán Cancela, Irene</creator><creator>Costoya, José A.</creator><creator>Crecente Campo, José</creator><creator>José Alonso, Maria</creator><creator>Marlow, Maria</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220625</creationdate><title>Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration</title><author>Teja Surikutchi, Bhanu ; Obenza-Otero, Rebeca ; Russo, Emanuele ; Zelzer, Mischa ; Golán Cancela, Irene ; Costoya, José A. ; Crecente Campo, José ; José Alonso, Maria ; Marlow, Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Intraperitoneal delivery</topic><topic>Localised drug</topic><topic>Localised drug delivery</topic><topic>Nanocapsule</topic><topic>Ovarian cancer</topic><topic>PEG hydrogel</topic><topic>Peritoneal metastases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teja Surikutchi, Bhanu</creatorcontrib><creatorcontrib>Obenza-Otero, Rebeca</creatorcontrib><creatorcontrib>Russo, Emanuele</creatorcontrib><creatorcontrib>Zelzer, Mischa</creatorcontrib><creatorcontrib>Golán Cancela, Irene</creatorcontrib><creatorcontrib>Costoya, José A.</creatorcontrib><creatorcontrib>Crecente Campo, José</creatorcontrib><creatorcontrib>José Alonso, Maria</creatorcontrib><creatorcontrib>Marlow, Maria</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teja Surikutchi, Bhanu</au><au>Obenza-Otero, Rebeca</au><au>Russo, Emanuele</au><au>Zelzer, Mischa</au><au>Golán Cancela, Irene</au><au>Costoya, José A.</au><au>Crecente Campo, José</au><au>José Alonso, Maria</au><au>Marlow, Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2022-06-25</date><risdate>2022</risdate><volume>622</volume><spage>121828</spage><epage>121828</epage><pages>121828-121828</pages><artnum>121828</artnum><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted]
Intraperitoneal (IP) drug delivery of chemotherapeutic agents, administered through hyperthermal intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosolized chemotherapy (PIPAC), is effective for the treatment of peritoneal malignancies. However, these therapeutic interventions are cumbersome in terms of surgical practice and are often associated with the formation of peritoneal adhesions, due to the catheters inserted into the peritoneal cavity during these procedures. Hence, there is a need for the development of drug delivery systems that can be administered into the peritoneal cavity. In this study, we have developed a nanocapsule (NCs)-loaded hydrogel for drug delivery in the peritoneal cavity. The hydrogel has been developed using poly(ethylene glycol) (PEG) and thiol-maleimide chemistry. NCs-loaded hydrogels were characterized by rheology and their resistance to dilution and drug release were determined in vitro. Using IVIS® to measure individual organ and recovered gel fluorescence intensity, an in vivo imaging study was performed and demonstrated that NCs incorporated in the PEG gel were retained in the IP cavity for 24 h after IP administration. NCs-loaded PEG gels could find potential applications as biodegradable, drug delivery systems that could be implanted in the IP cavity, for example at a the tumour resection site to prevent recurrence of microscopic tumours.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35595041</pmid><doi>10.1016/j.ijpharm.2022.121828</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-5173 |
ispartof | International journal of pharmaceutics, 2022-06, Vol.622, p.121828-121828, Article 121828 |
issn | 0378-5173 1873-3476 |
language | eng |
recordid | cdi_proquest_miscellaneous_2667786710 |
source | Elsevier |
subjects | Intraperitoneal delivery Localised drug Localised drug delivery Nanocapsule Ovarian cancer PEG hydrogel Peritoneal metastases |
title | Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A02%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20a%20nanocapsule-loaded%20hydrogel%20for%20drug%20delivery%20for%20intraperitoneal%20administration&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Teja%20Surikutchi,%20Bhanu&rft.date=2022-06-25&rft.volume=622&rft.spage=121828&rft.epage=121828&rft.pages=121828-121828&rft.artnum=121828&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2022.121828&rft_dat=%3Cproquest_cross%3E2667786710%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2667786710&rft_id=info:pmid/35595041&rfr_iscdi=true |